MARKET

BCTXZ

BCTXZ

Briacell Therapeutics Corp
NASDAQ
0.1696
+0.0346
+25.63%
Opening 13:55 02/11 EST
OPEN
0.1448
PREV CLOSE
0.1350
HIGH
0.1696
LOW
0.1448
VOLUME
15.40K
TURNOVER
--
52 WEEK HIGH
1.515
52 WEEK LOW
0.1200
MARKET CAP
--
P/E (TTM)
-0.0032
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Therapeutics Reports Tumor Regression in Phase 2 Study of Bria-IMT for Metastatic Breast Cancer
Reuters · 01/28 12:30
BRIACELL PATIENTS’ IMAGES SHOW REGRESSION AND RESOLUTION OF METASTASIZED TUMORS AND IMMUNE ACTIVATION
Reuters · 01/28 12:30
BriaCell Reports Extended Survival in Phase 2 Metastatic Breast Cancer Trial
Reuters · 01/27 17:05
BriaCell Highlights Extended >18-47 MONTHS SURVIVAL IN PHASE 2 METASTATIC BREAST CANCER PATIENTS
Reuters · 01/27 12:30
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Barchart · 01/27 06:30
BRIACELL THERAPEUTICS ANNOUNCES CLOSING OF US$30 MILLION PUBLIC OFFERING
Reuters · 01/15 21:05
US-LISTED SHARES OF BRIACELL THERAPEUTICS TUMBLE 55% AFTER CO PRICES $30 MLN PUBLIC OFFERING
Reuters · 01/14 14:31
BRIACELL THERAPEUTICS CORP - UNITS SOLD AT $5.59 PER UNIT FOR $30 MLN GROSS PROCEEDS
Reuters · 01/14 02:00
More

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXZ stock methods without spending real money on the virtual paper trading platform.